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Selecting an appropriate matrix solution is one of the most eﬀective means of increasing the ionization eﬃciency of
phosphopeptides in matrix-assisted laser-desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF-MS). In this
study, we systematically assessed matrix combinations of 2, 6-dihydroxyacetophenone (DHAP) and diammonium hydrogen
citrate (DAHC), and demonstrated that the low ratio DHAP/DAHC matrix was more eﬀective in enhancing the ionization of
phosphopeptides. Low femtomole level of phosphopeptides from the tryptic digests of α-casein and β-casein was readily detected
by MALDI-TOF-MS in both positive and negative ion mode without desalination or phosphopeptide enrichment. Compared
with the DHB/PA matrix, the optimized DHAP/DAHC matrix yielded superior sample homogeneity and higher phosphopeptide
measurement sensitivity, particularly when multiple phosphorylated peptides were assessed. Finally, the DHAP/DAHC matrix
was applied to identify phosphorylation sites from α-casein and β-casein and to characterize two phosphorylation sites from the
human histone H1 treated with Cyclin-Dependent Kinase-1 (CDK1) by MALDI-TOF/TOF MS.
1.Introduction
Reversible phosphorylation of serine, threonine, and tyro-
sine residues is one of the most common and important
regulatory posttranslational modiﬁcations of proteins and
plays a crucial role in many biological processes, including
cellular signal transduction, regulation of enzyme activities,
metabolic regulation, molecular recognition and biomolecu-
lar interaction, protein localization, cell diﬀerentiation and
proliferation [1–5]. Therefore, identifying phosphorylated
proteins is an important step to elucidate the structural and
functional role of the protein’s phosphorylation regulation.
Up to now, mass spectrometry, including matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrom-
etry (MALDI-TOF-MS) and electrospray ionization mass
spectrometry (ESI-MS) have been key technologies in
characterizing protein phosphorylation and phosphopro-
teome, and each approach presented strengths and limi-
tations [6–15]. However, because of the low and dynamic
stoichiometry of phosphorylation on proteins [16, 17]
and the low ionization eﬃciency of phosphopeptides, it
remains challenging to thoroughly characterize phospho-
rylation sites using mass spectrometry [18]. Considerable
eﬀort has been made recently to improve the ionization
eﬃciency of phosphopeptides by selecting and optimiz-
ing appropriate matrices with MALDI-TOF-MS. Several
materials have been employed in phosphopeptide analysis,
including 2, 5-dihydroxybenzoic acid (DHB) [19–21], 2, 4,
6-trihydroxyacetophenone (THAP) [22], and ionic liquid
matrices [20]. In addition, ammonium salts, including
diammonium hydrogen citrate (DAHC) [22–24], ammo-
nium acetate [23] and monoammonium phosphate [25],
and phosphoric acid [19–21]h a v eb e e nu s e da sm a t r i x
additives and have shown some ability to enhance phospho-
peptide ionization during MALDI-TOF-MS.
2, 6-Dihydroxyacetophenone (DHAP) was ﬁrst used by
Gorman et al. as a matrix for MALDI analysis of fragile
peptides, disulﬁde bonding, and small proteins, including2 Journal of Biomedicine and Biotechnology
phosphopeptides [24]. In recent years, Xu et al. reported
that the DHAP/DAHC matrix combination was used as
an eﬀective MALDI matrix in detecting methyl esteriﬁed
phosphopeptides by MALDI-TOF-MS [26, 27]. After sys-
tematic optimization in this study, we found that contrary
to previous reports, the matrix forms at a lower ratio of
DHAP/DAHC and that this ratio shows greater eﬃciency
in improving ionization ability of phosphopeptides. We
investigated the characteristics of an optimal DHAP/DAHC
matrix, and analyzed morphology and detection sensitivity
of phosphopeptides. Using tryptic digests of α-a n dβ-casein,
we demonstrated a CID MS/MS analysis of phosphopeptides
by MALDI-TOF/TOF-MS with an optimized DHAP/DAHC
matrix. Finally, we used this approach to analyze phospho-
rylation sites on human histone H1 treated with Cyclin-
Dependent Kinase-1 (CDK1).
2. Experimental
2.1. Materials. The chemicals 2, 6-dihydroxyacetophenone
(DHAP), 2, 5-dihydroxy-benzoic acid (DHB), diammonium
hydrogen citrate (DAHC), ammonium bicarbonate, triﬂuo-
roacetic acid (TFA), alkaline phosphatases, α-casein and β-
casein (both from bovine milk, purity by electrophoresis)
wereallpurchasedfromSigmaAldrich(St.Louis,MO,USA).
Cyclin-Dependent Kinase-1(CDK1) and human histone H1
were purchased from New England BioLabs, Inc. The
standard peptides VNQIGpTLSESIK (pT, purity > 95%)
and SGSLHRIpYTHQS (pY, purity > 85%) were synthesized
in Beijing Scilight Biotechnology Ltd. Co. (Beijing, China).
Sequencing grade modiﬁed trypsin (porcine) was purchased
from Promega Co. (Madison, WI, USA). HPLC-grade ace-
tonitrile and acetic acid were purchased from Mallinckrodt
Baker, Inc, (Phillipsburg, NJ, USA). Ethanol and ammonium
hydroxide solutions (NH3 · H2O) were purchased from
Beijing Chemical Company (Beijing China); ultrapure water
was obtained from a Milli-Q system (Millipore, Bedford,
MA, USA). All other chemicals used were of ACS or HPLC
grade.
2.2. Matrix Preparation. A 20-mg/mL dilution of DAHC
stocksolutionwaspreparedwithultrapurewater.TheDHAP
matrix stock solution was prepared by dissolving 10mg of
DHAP in 1mL of anhydrous ethanol. A series of modiﬁed
DHAP/DAHC matrix solutions were prepared by mixing
DHAP stock solution with DAHC stock solution at diﬀerent
ratios from 10 : 1 to 1 : 80 (v/v). The DHB/phosphoric
acid (PA) matrix was prepared as previously reported [19];
we modiﬁed this previous protocol by dissolving 20mg of
DHB in 1mL of 50% aqueous acetonitrile containing 1%
phosphoric acid.
2.3. Sample Preparation. α-Casein and β-casein (100nM
in 50mM ammonium bicarbonate buﬀer at pH 8.3)
were digested overnight at 37
◦C with trypsin at an
enzyme/substrate ratio of 1 : 25 (w/w). After digestion, TFA
was added into the sample solution at 1.0% to quench
the reaction. The digest was diluted with 60% acetonitrile
containing 0.1% TFA to produce a series of sample solutions
at concentrations of 1pmol/μL, 200fmol/μL, 50fmol/μL,
20fmol/μL, and 10fmol/μL. A stock solution containing
standard peptides pT( 1m M )a n dpY(1mM) was prepared
using ultra pure water. The solution was diluted with 60%
acetonitrile containing 0.1% TFA to 1pmol/μL, 200fmol/μL,
50fmol/μL, 20fmol/μL, and 10fmol/μL. All of the peptide
solutions prepared for DHB/PA measurements were diluted
with 1% phosphoric acid.
2.4. Human Histone H1 Phosphorylation and Digestion. The
phosphorylation reaction between histone H1 and CDK1
was carried out in vitro. Brieﬂy, the reaction solution was
prepared with 3μL1 0× CDK1 reaction buﬀer, 0.15μL
CDK1 (150U), 4μL histone H1 (1μg/μL), 100μMA T P ,
and 13μL water, then incubated at 30
◦Cf o r4 5m i n u t e s .
The phosphorylated histone H1 was then separated using
SDS-PAGE (12%) and stained with Coomassie Brilliant
Blue using microwave-assisted methods [28]. The in-gel
digestion of phosphorylated histone H1 was performed
as follows: the band of histone H1 was excised from the
polyacrylamide gel, washed twice with water, and destained
with 40% acetonitrile/50mM NH4HCO3. The gel pieces
were dehydrated with 100% acetonitrile and dried for 5
min using a speedvac. Disulﬁde bonds were reduced with
DTT (10mM, 56
◦C, 45 minutes), and the free sulfhydryl
groups were alkylated with iodoacetamide (55mM, 25
◦C,
60 minutes in the dark). Gel pieces were washed with
50mMNH4HCO3,50%acetonitrile/50mMNH4HCO3,and
dehydrated with 100% acetonitrile. After drying with a
speedvac, the gel was rehydrated using 100ng/μL trypsin
(50mM NH4HCO3,p H8 . 3 )o ni c ef o r3 0m i n u t e s ,a n d
the digestion was carried out at 37
◦Cf o r6 0m i n u t e sa n d
then quenched with 1.0% TFA. The tryptic peptides were
extracted twice with 60% acetonitrile containing 0.1% TFA,
and then the combined digest solution was concentrated to
10μL under vacuum.
2.5. Sample Analysisby MALDI-TOF-MSand MALDI-TOF2-
MS. MALDI-TOF-MS analysis of peptides was performed
using an AXIMA-CFR plus MALDI-TOF mass spectrometer
(Shimadzu/Kratos, Manchester, UK) equipped with a pulsed
nitrogen laser operated at 337nm. Positive/negative ion
MALDI mass spectra were acquired in the reﬂectron mode
under the following parameters: ion source, 20/−20kv,
lens, 6.3/−6.3kv, pulsed extraction, −2.5/2.5kv, reﬂec-
tion, 25/−25kV. High-energy CID MS/MS was performed
with the AXIMA-TOF2 MALDI mass spectrometer (Shi-
madzu/Kratos, Manchester, UK), equipped with the same
pulsed 337-nm nitrogen laser. Operation parameters were:
ion source, 20.0kV; lens, 6.5kV; pulsed extraction, −2.5kV;
and reﬂectron, 24.4kV.
To prepare for MALDI-TOF-MS analysis, 1μLo fp e p t i d e
solution was mixed with 3μLo fm a t r i xs o l u t i o ni na n
Eppendorf tube, and 1μL of the peptide/matrix solution was
spotted onto the MALDI sample plate and then crystallized
either under vacuum (when DHAP/DAHC was used as
matrix) or in the air (when DHB/PA was used as matrix).Journal of Biomedicine and Biotechnology 3
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Figure 1: The MALDI mass spectra of the tryptic digest of α-casein (250fmol on target) measured in positive ion mode with DHAP/DAHC
matrix at diﬀerent ratios (10:1 to 1:80). The signal intensity is magniﬁed 10-fold in the m/z range from 2575 to 3025. The number of sites
on each phosphopeptide is equal to the number of asterisks (∗) shown.
Measurements using DHAP/DAHC were performed by
detecting 15–20 diﬀerent positions on the broad outer zone
(see discussion below) for each sample to accumulate a
total of 200 proﬁles (5 shots per proﬁle). For measurements
with DHB/PA, a total of 200 proﬁles (5 shots per proﬁle)
were accumulated by searching for 10–15 hot spots for each
sample. All experiments were repeated three times.
The standard peptide pT (250fmol on target) was
used to determine sample homogeneity of the matrix.
On each sample spot, 196 (14 × 14) positions were
selected manually to ensure a full overview over the sample
preparation. For each position, 50 proﬁles (5 shots per
proﬁle) were accumulated in positive ion mode. The signal
intensities of pT in each position were recorded for further
analysis.
Mass spectrometry data were processed with Launchpad
2.7.1 software (Shimadzu/Kratos, Manchester, UK). The
data of the CID MS/MS spectra of phosphopeptides from
histone H1 were compared to the SwissProt 56.6 protein
sequence database (Homo sapiens) using the on-line MAS-
COT database search engine (Matrix Science, London, UK)
with the following parameters: trypsin with three missed
cleavages; average mass values; peptide mass tolerance: ±0.8
Da; fragment mass tolerance: ±1.0 Da; ﬁxed modiﬁcations:
Carbamidomethyl (C), variable modiﬁcations: Oxidation
(M), phosphor (ST). Only the peptides with ions score above
38 were accepted as signiﬁcant matches.
3. Results and Discussion
3.1. Optimization of DHAP/DAHC Matrix Combination.
The solution composition of the matrix is a factor that
signiﬁcantly inﬂuences the ionization eﬃciency and the
quality of MALDI mass spectra [29]. Therefore, we prepared
as e r i e so fd i ﬀerent ratios of DHAP (10mg/mL) and DAHC
(20mg/mL) matrix solutions (10:1, 5:1, 1:1, 1:4, 1:8,
1:16, 1:20, 1:30, 1:40, 1:50, 1:60, and 1:80v/v) and
investigated these matrix combinations using the tryptic
digest of α-casein, which contains nine phosphopeptides
(Tα1-Tα9) and some nonphosphopeptides (such as T4, T10,
T11, T18) (see Table 1). Figure 1 shows a comparison of the
MALDI-TOF-MS analysis of the tryptic digest of α-casein
(250fmol on target) using matrix DHAP/DAHC at diﬀerent
ratios in positive ion mode. The signal intensity of phospho-
peptides (especially for multiple phosphorylated peptides)
changed dramatically with the ratio of DHAP/DAHC. It
was clear that all phosphopeptides could be easily detected
with a low DHAP/DAHC matrix ratio in the range of 1:30
to 1:60. In an optimal matrixsolution, the concentration4 Journal of Biomedicine and Biotechnology
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Figure 2: Top two views show the MALDI samples containing the phosphopeptide pT using (a) DHAP/DAHC matrix and (b) DHB/PA
matrix. The two center pictures show the signal intensities of the phosphopeptides pT (250fmol on target) measured with (c) DHAP/DAHC
matrix and (d) DHB/PA matrix. The images only show a cut at signal intensity of 400mv for clarity. The positions with signal intensities
above 400mv are indicated in purple. The bottom row (e) shows a schematic of the data acquisition method for investigating sample
homogeneity of the matrix. In total, 196 positions were selected as a 14 × 14 spots array to cover the crystalline matrix/analyte layer, and 50
proﬁles (5 shots per proﬁles) were accumulated at each position.
of DHAP was 1.6–3.3mg/mL, which is lower than the
concentration of 10–15mg/mL used by other groups [24,
26, 27]. Once the DHAP/DAHC ratio was down to 1:80,
most multiple phosphorylated peptides could no longer be
detected, likely because there were not suﬃcient numbers of
DHAP molecules to transfer the laser energy to the peptides
to be protonated.
Another interesting phenomenon apparent in Figure 1:
the signal intensity of nonphosphopeptides was stable (T3),
enhanced (T10) or weakened (T11, T4, T18) with theJournal of Biomedicine and Biotechnology 5
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Figure 3: The MALDI mass spectra of the tryptic digest of (a) and (c) α-casein and (b) and (d) β-casein measured in positive (upper) and
negative (lower) ion modes with the DHAP/DAHC matrix. The amount of the tryptic peptides mixture ranged from 5fmol to 250fmol on
target. The signal intensity is magniﬁed 5-fold in the m/z range from 2400 to 3150 in section a.6 Journal of Biomedicine and Biotechnology
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Figure 4: The MALDI mass spectra of two synthesized phosphopeptides pTa n dpY mixed at equimolarity from 5 to 250fmol on target,
which were measured in positive (a) and negative (b) ion mode with DHAP/DAHC, respectively.
Table 1: The peptides investigated in this study∗.
Peptide ID Sequence No. Sequence [M+ H]
+
Theo B+B
Tα1 aa 106–119 VPQLEIVPNpSAEER 1660.79 260
Tα2 aa 104 –119 KYKVPQLEIVPNpSAEER 1951.95 −710
Tα3 aa 43–58 DIGpSEpSTEDQAMEDIK 1927.68 3960
Tα4 aa 59–79 QMEAEpSIpSpSpSEEIVPNpSVEQK 2720.90 3680
Tα5 aa 37–58 VNELpSKDIGpSEpSTEDQAMEDIK 2678.02 3840
Tα6 aa 138–149 TVDMEpSTEVFTK 1466.60 −210
Tα7 aa 46–70 NANEEEYSIGpSpSpSEEpSAEVATEEVK 3008.02 7100
Tα8 aa 1–21 KNTMEHVpSpSpSEESIIpSQETYK 2747.00 2810
Tα9 aa 2–21 NTMEHVpSpSpSEESIIpSQETYK 2618.91 2350
Tβ1a a 3 3 – 4 8 F Q pSEEQQQTEDELQDK 2061.82 6200
Tβ2 aa 1–25 RELEELNVPGEIVEpSLpSpSpSEESITR 3122.26 −220
T10 aa 81–91 ALNEINQFYQK 1367.70 −750
T4 aa 23–34 FFVAPFPEVFGK 1384.73 −5530
T3 aa 8–22 HQGLPQEVLNENLLR 1759.59 −590
T11 aa 91–100 YLGYLEQLLR 1267.71 −6480
T18 aa 132–150 EPMIGVNQELAYFYPELFR 2316.14 −6900
pT — VNQIGpTLSESIK 1368.44 −310
pY — SGSLHRIpYTHQS 1465.48 2300
∗Phosphopeptides in tryptic digest of βcasein and αcasein are denoted as Tβ1∼2a n dT α1∼9, respectively. The sites of phosphorylation are indicated with the
letter “p” in the listed peptide sequences. T3, T4, T11, and T18 are nonphosphorylated peptide from αcasein S1. T10 is a nonphosphorylated peptide from α-
casein S2. pTa n dpY are the synthesized standard phosphopeptides. [M+H]+ denotes the theoretical monoisotopic m/z mass. “B+B” means Bull and Breese
Index for peptides calculated by the Masslynx software (Waters/Micromass).Journal of Biomedicine and Biotechnology 7
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Figure 5: Tryptic digests of α- (upper) and β-casein (lower) (12.5–250fmol on target) were detected with DHAP/DAHC (a) and (c) and
DHB/PA (b) and (d) by MALDI-TOF MS in positive mode. DHAP/DAHC positions were selected randomly in the outer ring of the sample;
for DHB/PA, only signals in hot spots were collected. In total, 200 proﬁles were accumulated for each sample. The number of sites on each
phosphopeptide was equal to the number of asterisks (∗).8 Journal of Biomedicine and Biotechnology
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Figure 7: The MALDI MS analysis of phosphopeptides from CDK1-treated human histone H1. MS spectra of the tryptic peptides from
CDK1-treated histone H1 with the untreated (Figure 7(a)) and alkaline phosphatase-treated histone H1 (Figure 7(b)). The two panels on
the right show the magniﬁed spectra to indicate the two phosphopeptides labeled with asterisks (∗). The MALDI-TOF/TOF-MS analysis of
phosphorylation sites on the two monophosphopeptides VApTPKKASKPK, m/z 1234.7 (c), APTKKPKApTPVKK, m/z 1473.9 (d) from the
CDK1-treated human histone H1. The neutral-loss peak of phosphopeptide was noted as [MH-H3PO4]+. The fragment patterns of peptides
were shown in the magniﬁed MS/MS spectra. “B” in the amino sequence indicates a dehydroamino-2-butyric acid residue converted from a
phosphothreonine residue by beta-elimination of H3PO4. All the spectra were detected using DHAP/DAHC matrix in the positive mode.10 Journal of Biomedicine and Biotechnology
change of the DHAP/DAHC ratio. We calculated the Bull
and Breese Index (BB Index) [19] of these peptides, an
index generally used to reﬂect the hydrophobic/hydrophilic
nature of peptides. Higher BB Index values are associated
with more hydrophilic peptides. For the phosphopeptide, we
calculated the BB Index by replacing the phosphoserine or
phosphothreonine residues with glutamic acid [19]. By com-
paring the BB Index of peptides listed in Table 1,w ef o u n d
that the phosphopeptides were nearly hydrophilic peptides
with high BB Indices and that the nonphosphopeptides for
which signal intensity was weakened at low DHAP/DAHC
ratio were highly hydrophobic with lower BB Index (T4:
−5530, T11:−6480, T18:−6900). The nonphosphopeptide
T10 for which the ion signal was enhanced at lower ratios
of DHAP/DAHC was found to be slightly hydrophobic
with a BB Index of −750. These ﬁndings indicated that
the optimal DAHC/DHAP matrix tended to detect more
hydrophilicpeptides.Mostphosphopeptidesarehydrophilic,
so we propose that the low ratio of DHAP/DAHC matrix
could increase cocrystallization between matrix and phos-
phopeptides and further improve ionization eﬃciency of
phosphopeptide in MALDI MS.
3.2. Sample Homogeneity. In this study, the phosphopeptide
pT (250 fmol on target) was used to investigate the sample
homogeneity of optimized DHAP/DAHC matrix, and for
a comparison, we chose matrix combination of 2,5-DHB
with 1% phosphoric acid, a currently popular matrix used
for detection of phosphopeptide [30–32]. It was apparent
from the photographs of the MALDI sample spots that
there was a dramatic diﬀerence between the optimized
DHAP/DAHC (Figure 2(a)) and DHB/PA (Figure 2(b)).
Small crystals formed in a DHAP/DAHC sample spot while
larger, needle-like crystals formed in a DHB/PA sample
spot. Furthermore, 196 (14 × 14) positions on the target
were measured covering the crystalline layer for a full
overview (Figure 2(e)), and the MS signal intensities of pT
were monitored. The majority of the outer zones of the
crystalline samples exhibited high signal intensities, except
for a small center zone when DHAP/DAHC used as matrix
(Figure 2(c)). In comparison, the crystalline DHB/PA matrix
exhibited the hot-spot phenomenon, signals were primarily
observed in the narrow, inhomogeneous ring at the edge
of the sample layer, and the inner position almost did
not exhibit any signal (Figure 2(d)). Therefore, the samples
prepared with DHAP/DAHC were more homogeneous than
those prepared with a DHB/PA matrix, reducing the need
for time-consuming hot-spot searches. Based on the sample
homogeneity of DHAP/DAHC and DHB/PA, in the next
experiments, the data acquisition with DHAP/DAHC was
carried out by randomly measuring the outer zone of the
sample layer, while data were acquired from the DHB/PA
matrix by searching for hot spots of sample.
3.3. Sensitivity Measurement of Phosphopeptides with the
DHAP/DAHC Matrix. In order to further evaluate the mea-
surement sensitivity of phosphopeptides with the optimal
DHAP/DAHC matrix, the tryptic digest of α-casein and β-
casein with 2.5–250fmol on the target were detected by
MALDI-TOF MS in both positive and negative ion mode.
Figure 3 shows that all eleven phosphopeptides from α-
casein and β-casein could be detected with signal-to-noise
(S/N) ratios greater than 3 at the low amount of 12.5fmol in
thepositivemode(a)and(b)anddetectedataloweramount
of 5fmol in the negative mode (c) and (d). The monophos-
phopeptides (Tα1a n dT β1) could still be observed at
2 . 5f m o lo nt a r g e ti nn e g a t i v ei o nm o d e( Figure 3(c)). Phos-
phopeptides generally exhibited better S/N ratios in the MS
spectra in negative ion mode than that in positive ion mode,
although, consistent with previous reports [19], the absolute
signal intensity of phosphopeptide was usually lower in
negativeionmode.Becausealltrypticphosphopeptidesfrom
α-casein and β-casein are serine-phosphorylated peptides,
a threonine-phosphorylated peptide pT and a tyrosine-
phosphorylated peptide pY (2.5–250fmol on target) were
used to investigate whether the DHAP/DAHC matrix had
a generic nature in detection of phosphopeptides. As
expected, pTa n dpYc o u l db er e a d i l yd e t e c t e dd o w nt o
5fmol on the target in both positive and negative modes
(Figure 4).
We further directly compared optimized DHAP/DAHC
to DHB/PA. Tryptic digests of α-casein and β-casein (12.5–
250fmol on target) were detected using these two matrices
(Figure 5). When using the DHAP/DAHC matrix, all the
phosphopeptides could readily be detected at three diﬀerent
sample amounts. By comparison, when DHB/PA was used
as the matrix, although all the phosphopeptides in 250fmol
digest (on target) could be detected with DHB/PA, the
amount of digest went down to 50fmol (on the target),
and only Tα1, Tα2, Tα3, Tα6, Tβ1, and Tβ2c o u l db e
observed. Furthermore, when the amount of digest went
down to 12.5fmol, only Tα1a n dT β1w e r ed e t e c t e d ,w i t h
weak signals. Comparing these results, it was clear that
compared with DHB/PA, the optimized DHAP/DAHC had
comparative sensitivity in the detection of singly phospho-
rylated peptides (Tα1a n dT β1), but greater sensitivity in
the detection of multiply phosphorylated peptides, such as
Tβ2( 4 p)a n dT α4( 5 p). Herein, we suggest that sample
should be analyzed immediately after sample preparation
when optimized DHAP/DAHC matrix used, as the crystals
might not last too long under atmospheric conditions and in
vacuo.
3.4. Sequencing of Phosphopeptides with High Energy CID
MS/MS. We employed the AXIMA-TOF2 MALDI mass
spectrometer (Shimadzu/Kratos, Manchester, UK) to per-
form high energy CID MS/MS of phosphopeptides to char-
acterize phosphorylation sites. Figure 6 shows the MS/MS
spectra of three phosphopeptides Tβ1, Tα3, and Tβ2f r o mα-
casein and β-casein (250fmol on target) with DHAP/DAHC
as matrix. The number of [MH-98]+ or [MH-80]+ peaks
in the MS/MS spectra indicated the number of phosphate
groups in each phosphorylated peptide, and the fragment
ions including a, b, and y ions clearly show the phosphoryla-
tion sites of the phosphopeptides Tβ1, Tα3, and Tβ2. These
results demonstrated the feasibility of MALDI-TOF/TOFJournal of Biomedicine and Biotechnology 11
MS with the DHAP/DAHC matrix for the analysis of the
phosphorylation sites of phosphopeptides, including singly
and multiply phosphorylated peptides.
3.5. Application of the Optimized DHAP/DAHC Matrix in
the Characterization of Phosphorylated Human Histone H1.
Further investigating the practicality of the DHAP/DAHC
matrix, we used this approach to characterize human histone
H1 phosphorylated with CDK1. Experimentally, phospho-
rylated histone H1 was separated by SDS-PAGE and in-
gel digested by trypsin. In order to generate appropriate
peptide sizes for MALDI-MS analysis, since the sequence
of histone proteins is known to contain many lysine and
arginine residues, the trypsin digestion time was optimized
and reduced to 1 hour. Figure 7(a) shows the results of
the MALDI-TOF-MS analysis of the tryptic digest of the
phosphorylated histone H1 without the desalting step,
directly detected with the optimized DHAP/DAHC matrix
in positive ion mode. After performing data processing using
the on-line MASCOT search engine, 31 peptides, including
2 possible phosphopeptides (in Figure 7(a) labeled with
“∗”), were assigned to human histone H1, and 81% of the
sequence was covered. These two peptides corresponded to
the two monophosphopeptides of histone H1, comprising
amino acids 117–127 (VATPKKASKPK, 1234.7m/z; possible
phosphorylation sites indicated with underlined letters)
and 133–145 (APTKKPKATPVKK, 1473.9m/z). The tryptic
sample of H1 was also analyzed with DHB/PA, but the
two peaks of the phosphopeptide were lower than those
in Figure 7(a) (see Figure S1). To validate the MASCOT
searching result for the two phosphorylated peptides, we
compared the mass spectra of tryptic peptides of H1 before
and after treatment with alkaline phosphatase, which can
cleave the phosphate group from phosphopeptides. It was
clear that the two peptide peaks (marked with asterisks in
Figure 7(a)) had disappeared and two new peaks with a mass
shift of 80Da (HPO3 = 80 Da) were visible (Figure 7(b)).
This demonstrated that the two peptides (marked with
asterisks in Figure 7(a) were singly phosphorylated peptides.
To identify the phosphorylation sites, we used MALDI-
TOF/TOF MS to perform MS/MS analysis of the two
peptides (Figure 7(c) and 7(d)). Only one neutral-loss peak
corresponding to [MH-H3PO4]+ indicated that both phos-
phopeptides were monophosphopeptides. After a MASCOT
search,thephosphorylationsitesofthetwophosphopeptides
were determined to be APTKKPKApTPVKK (pT indicating
the phosphothreonine) and VApTPKKASKPK with ion
scores of 53 and 50, respectively (scores exceeding 38 were
accepted as signiﬁcant matches).
In general, the protein phosphorylation sites by a par-
ticular protein kinase shared a set of “consensus sequence”,
whichisnecessaryandsuﬃcientforrecognitionbythekinase
[33]. To further validate the phosphorylation sites of histone
H1 identiﬁed with MALDI-TOF/TOF MS, we compared the
two phosphorylated peptide sequences with the consensus
sequence pS/pT-P-X-R/K, most frequently recognized by
CDK1 [34, 35], and found that both phosphopeptide
sequences were consistent with the consensus sequence.
These results thus demonstrate that the DHAP/DAHC
matrix was robust and eﬀective in analyzing the protein
phosphorylation of the biological sample by MALDI-MS.
4. Conclusion
By optimizing the matrix solution composition, we found
that a low ratio of DHAP/DAHC formulation was more
eﬃcient in detecting phosphopeptides than earlier protocols.
Compared with DHB/PA, the optimized DHAP/DAHC
exhibited higher sample homogeneity, and the phosphopep-
tides in tryptic digests of α-a n dβ-casein without desalting
and phosphopeptide enrichment could be measured with
a higher sensitivity. Further, the optimized DHAP/DAHC
showed high energy CID MS/MS analysis of the phos-
phorylation sites of phosphopeptides, including multiple
phosphorylated peptides, and we successfully applied this
method to the characterization of the phosphorylation sites
of CDK1-treated human histone H1.
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